OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
19.98
-0.58 (-2.82%)
Oct 30, 2025, 2:20 PM EDT - Market open
OptimizeRx Market Cap
OptimizeRx has a market cap or net worth of $370.92 million as of October 30, 2025. Its market cap has increased by 207.56% in one year.
Market Cap
370.92M
Enterprise Value
389.07M
1-Year Change
207.56%
Ranking
Category
Stock Price
$19.98
Market Cap Chart
Since June 22, 2018, OptimizeRx's market cap has increased from $34.20M to $370.92M, an increase of 984.55%. That is a compound annual growth rate of 38.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 381.70M | 326.48% |
| Dec 31, 2024 | 89.50M | -65.55% |
| Dec 29, 2023 | 259.80M | -9.85% |
| Dec 30, 2022 | 288.20M | -73.89% |
| Dec 31, 2021 | 1.10B | 134.43% |
| Dec 31, 2020 | 470.80M | 223.35% |
| Dec 31, 2019 | 145.60M | 10.47% |
| Dec 31, 2018 | 131.80M | 285.38% |
| Jun 22, 2018 | 34.20M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.36B |
| Johnson & Johnson | 445.89B |
| AbbVie | 397.03B |
| UnitedHealth Group | 325.63B |
| AstraZeneca | 255.54B |
| Novartis AG | 239.27B |
| Novo Nordisk | 229.86B |
| Abbott Laboratories | 217.66B |